GlassScriptPhysician profile
Sandip Karki
NPI 1750992129
$541.75
in general payments reported to CMS, 2019-2025
7 companies · $198 in 2025
The $198 reported for 2025 was more than what 76% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $170 · 2024: $173 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $137.44 | 2023-2025 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2023 | Lokelma |
| Pfizer INC. | $93.89 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $92.92 | 2024 | Xarelto |
| Stryker Corporation | $39.51 | 2025 | Intri24 Introducer Sheath |
| Merck Sharp & Dohme LLC | $30.14 | 2023-2025 | Zerbaxa, Dificid, Recarbrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.11 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandip Karki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.